{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T09:44:39Z","timestamp":1788515079809,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.drugpo.2017.06.003","type":"journal-article","created":{"date-parts":[[2017,7,5]],"date-time":"2017-07-05T12:01:15Z","timestamp":1499256075000},"page":"112-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"special_numbering":"C","title":["US regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations"],"prefix":"10.1016","volume":"46","author":[{"given":"George Jay","family":"Unick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ciccarone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.drugpo.2017.06.003_bib0005","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1111\/add.13491","article-title":"Non-medical use of prescription opioids is associated with heroin initiation among US veterans: A prospective cohort study","volume":"111","author":"Banerjee","year":"2016","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.drugpo.2017.06.003_bib0010","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jpeds.2015.04.071","article-title":"Nonmedical prescription opioid use in childhood and early adolescence predicts transitions to heroin use in young adulthood: A national study","volume":"167","author":"Cerda","year":"2015","journal-title":"Journal of Pediatrics"},{"issue":"1","key":"10.1016\/j.drugpo.2017.06.003_bib0015","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0955-3959(02)00219-0","article-title":"With both eyes open: Notes on a disciplinary dialogue between ethnographic and epidemiological research among injection drug users","volume":"14","author":"Ciccarone","year":"2003","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2017.06.003_bib0020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugpo.2017.06.010","article-title":"Editorial: Fentanyl in the US heroin supply: a rapidly changing risk environment","volume":"46","author":"Ciccarone","year":"2017","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2017.06.003_bib0025","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.drugpo.2017.06.004","article-title":"Heroin uncertainties: Exploring users\u2019 perceptions of fentanyl-adulterated and-substituted \u2018heroin\u2019","volume":"46","author":"Ciccarone","year":"2017","journal-title":"International Journal of Drug Policy"},{"issue":"18","key":"10.1016\/j.drugpo.2017.06.003_bib0030","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1056\/NEJMc1505541","article-title":"Shifting patterns of prescription opioid and heroin abuse in the United States","volume":"373","author":"Cicero","year":"2015","journal-title":"The New England Journal of Medicine"},{"issue":"7","key":"10.1016\/j.drugpo.2017.06.003_bib0035","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamapsychiatry.2014.366","article-title":"The changing face of heroin use in the United States: Aretrospective analysis of the past 50 years","volume":"71","author":"Cicero","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.drugpo.2017.06.003_bib0040","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMra1508490","article-title":"Relationship between nonmedical prescription-opioid use and heroin use","volume":"374","author":"Compton","year":"2016","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.drugpo.2017.06.003_bib0045","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMsa1406143","article-title":"Trends in opioid analgesic abuse and mortality in the United States","volume":"372","author":"Dart","year":"2015","journal-title":"The New England Journal of Medicine"},{"issue":"7","key":"10.1016\/j.drugpo.2017.06.003_bib0050","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJMp1615145","article-title":"Addressing the fentanyl threat to public health","volume":"376","author":"Frank","year":"2017","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.drugpo.2017.06.003_bib0055","first-page":"1","article-title":"Prescription opioid analgesic use among adults: United States, 1999\u20132012","volume":"189","author":"Frenk","year":"2015","journal-title":"NCHS Data Brief"},{"issue":"33","key":"10.1016\/j.drugpo.2017.06.003_bib0060","doi-asserted-by":"crossref","first-page":"837","DOI":"10.15585\/mmwr.mm6533a2","article-title":"Fentanyl law enforcement submissions and increases in synthetic opioid-involved overdose deaths\u201427 States, 2013\u20132014","volume":"65","author":"Gladden","year":"2016","journal-title":"The Morbidity and Mortality Weekly Report (MMWR)"},{"issue":"3","key":"10.1016\/j.drugpo.2017.06.003_bib0065","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s10900-010-9231-z","article-title":"Circumstances, pedagogy and rationales for injection initiation among new drug injectors","volume":"35","author":"Goldsamt","year":"2010","journal-title":"The Journal of Community Health"},{"issue":"3","key":"10.1016\/j.drugpo.2017.06.003_bib0070","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/10550490701375293","article-title":"Illicit use of opioids: Is OxyContin a \"gateway drug\"?","volume":"16","author":"Grau","year":"2007","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.drugpo.2017.06.003_bib0075","series-title":"Trend HCUP NIS trend weights","author":"Healthcare Cost and Utilization Project (HCUP)","year":"2015"},{"key":"10.1016\/j.drugpo.2017.06.003_bib0080","first-page":"1","article-title":"Drug overdose deaths in the United States, 1999\u20132015","volume":"273","author":"Hedegaard","year":"2017","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.drugpo.2017.06.003_bib0085","series-title":"Nationwide inpatient sample (NIS) redesign final report","author":"Houchens","year":"2014"},{"issue":"1\u20132","key":"10.1016\/j.drugpo.2017.06.003_bib0090","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2013.01.007","article-title":"Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers\u2014United States, 2002\u20132004 and 2008\u20132010","volume":"132","author":"Jones","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"26","key":"10.1016\/j.drugpo.2017.06.003_bib0095","first-page":"719","article-title":"Vital signs: Demographic and substance use trends among heroin users\u2014United States, 2002\u20132013","volume":"64","author":"Jones","year":"2015","journal-title":"The Morbidity and Mortality Weekly Report (MMWR)"},{"issue":"8\u20139","key":"10.1016\/j.drugpo.2017.06.003_bib0100","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3109\/10826084.2015.1007679","article-title":"Ready for retirement: The gateway drug hypothesis","volume":"50","author":"Kleinig","year":"2015","journal-title":"Substance Use & Misuse"},{"issue":"1","key":"10.1016\/j.drugpo.2017.06.003_bib0105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.annemergmed.2016.08.445","article-title":"Novel synthetic opioids: An opioid epidemic within an opioid epidemic","volume":"69","author":"Lucyk","year":"2017","journal-title":"Annals of Emergency Medicine"},{"issue":"2","key":"10.1016\/j.drugpo.2017.06.003_bib0110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drugpo.2013.10.004","article-title":"\"Every \u2018never\u2019 I ever said came true\": Transitions from opioid pills to heroin injecting","volume":"25","author":"Mars","year":"2014","journal-title":"International Journal of Drug Policy"},{"issue":"4","key":"10.1016\/j.drugpo.2017.06.003_bib0115","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/jamapsychiatry.2017.0113","article-title":"Changes in US lifetime heroin use and heroin use disorder","volume":"74","author":"Martins","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugpo.2017.06.003_bib0120","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drugalcdep.2014.10.012","article-title":"Supervised injection services: What has been demonstrated? A systematic literature review","volume":"145","author":"Potier","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2017.06.003_bib0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12873-016-0075-4","article-title":"Use of diagnosis codes for detection of clinically significant opioid poisoning in the emergency department: A retrospective analysis of a surveillance case definition","volume":"16","author":"Reardon","year":"2016","journal-title":"BMC Emergency Medicine"},{"issue":"5051","key":"10.1016\/j.drugpo.2017.06.003_bib0130","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths\u2014United States, 2010\u20132015","volume":"65","author":"Rudd","year":"2016","journal-title":"The Morbidity and Mortality Weekly Report (MMWR)"},{"key":"10.1016\/j.drugpo.2017.06.003_bib0135","series-title":"SAS\/ACCESS 9.4 interface to ADABAS: Reference","author":"SAS Institute Inc","year":"2013"},{"issue":"5","key":"10.1016\/j.drugpo.2017.06.003_bib0140","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1177\/003335491412900507","article-title":"Drug overdose surveillance using hospital discharge data","volume":"129","author":"Slavova","year":"2014","journal-title":"Public Health Reports"},{"issue":"14","key":"10.1016\/j.drugpo.2017.06.003_bib0145","doi-asserted-by":"crossref","first-page":"382","DOI":"10.15585\/mmwr.mm6614a2","article-title":"Characteristics of fentanyl overdose\u2014Massachusetts, 2014\u20132016","volume":"66","author":"Somerville","year":"2017","journal-title":"The Morbidity and Mortality Weekly Report (MMWR)"},{"key":"10.1016\/j.drugpo.2017.06.003_bib0150","series-title":"Stata Statistical Software: Release 14","author":"StataCorp","year":"2015"},{"key":"10.1016\/j.drugpo.2017.06.003_bib0155","series-title":"NFLIS brief: Fentanyl, 2001\u20132005","author":"U.S. Drug Enforcement Administration Diversion Control Division","year":"2017"},{"issue":"11","key":"10.1016\/j.drugpo.2017.06.003_bib0160","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1111\/add.12664","article-title":"The relationship between US heroin market dynamics and heroin-related overdose, 1992\u20132008","volume":"109","author":"Unick","year":"2014","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.drugpo.2017.06.003_bib0165","doi-asserted-by":"crossref","first-page":"e54496","DOI":"10.1371\/journal.pone.0054496","article-title":"Intertwined epidemics: National demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993\u20132009","volume":"8","author":"Unick","year":"2013","journal-title":"PLoS One"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917301664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917301664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T17:45:07Z","timestamp":1583862307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395917301664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":33,"alternative-id":["S0955395917301664"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.06.003","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"US regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}